表紙:敗血症診断の世界市場(2022年~2028年):製品別、技術別、地域別の市場規模調査と予測
市場調査レポート
商品コード
1073841

敗血症診断の世界市場(2022年~2028年):製品別、技術別、地域別の市場規模調査と予測

Global Sepsis Diagnostics Market Size study, by Product, by Technology and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
敗血症診断の世界市場(2022年~2028年):製品別、技術別、地域別の市場規模調査と予測
出版日: 2022年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の敗血症診断の市場規模は、2021年に約4億6,147万米ドルとなり、2022年~2028年の予測期間中に9.00%以上の健全な成長率で成長すると予想されています。市場を牽引する主な要因には、院内感染の増加や敗血症の高い発生率、新興国での迅速な診断の発展と成長機会などがあります。しかし、熟練した専門家の不足と自動診断装置の高コストが、予測期間における市場の成長を阻害しています。

当レポートでは世界の敗血症診断市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の敗血症診断市場:定義と範囲

第3章 世界の敗血症診断:市場力学

  • 敗血症診断市場:影響分析(2020年~2028年)

第4章 世界の敗血症診断市場:業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価:COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19前とCOVID-19後の市場シナリオ

第6章 世界の敗血症診断市場:製品別

  • 市場のスナップショット
  • 実績:潜在的な分析
  • 市場規模の推計と予測(2019年~2028年)
  • サブセグメント分析
    • 血液培養媒体
    • アッセイと試薬
    • 機器
    • ソフトウェア

第7章 世界の敗血症診断市場:技術別

  • 市場のスナップショット
  • 実績:潜在的な分析
  • 市場規模の推計と予測(2019年~2028年)
  • サブセグメント分析
    • 血液培養
    • イムノアッセイ
    • 分子診断
    • フローサイトメトリー
    • マイクロフルイディクス
    • バイオマーカー

第8章 世界の敗血症診断市場:地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第9章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • Axis-Shield Diagnostics(英国)
    • Becton, Dickinson and Company(米国)
    • Danaher Corporation(米国)
    • Thermo Fisher Scientific(米国)
    • Bruker Corporation(米国)
    • Abbott Laboratories(米国)
    • Axis-Shield Diagnostics(英国)
    • Quidel Corporation(米国)
    • EKF Diagnostics(英国)
    • Seegene Inc.(韓国)

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Sepsis Diagnostics market, report scope
  • TABLE 2. Global Sepsis Diagnostics market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Sepsis Diagnostics market estimates & forecasts by Product 2019-2028 (USD Billion)
  • TABLE 4. Global Sepsis Diagnostics market estimates & forecasts by Technology 2019-2028 (USD Billion)
  • TABLE 5. Global Sepsis Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 6. Global Sepsis Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 7. Global Sepsis Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 8. Global Sepsis Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Sepsis Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Sepsis Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Sepsis Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Sepsis Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Sepsis Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Sepsis Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. U.S. Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. U.S. Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 17. U.S. Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 18. Canada Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 19. Canada Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 20. Canada Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 21. UK Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 22. UK Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 23. UK Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 24. Germany Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 25. Germany Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 26. Germany Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 27. RoE Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 28. RoE Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 29. RoE Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 30. China Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 31. China Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 32. China Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 33. India Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 34. India Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 35. India Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 36. Japan Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 37. Japan Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 38. Japan Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 39. RoAPAC Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 40. RoAPAC Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 41. RoAPAC Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 42. Brazil Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 43. Brazil Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 44. Brazil Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 45. Mexico Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 46. Mexico Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 47. Mexico Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 48. RoLA Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 49. RoLA Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 50. RoLA Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 51. Row Sepsis Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 52. Row Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 53. Row Sepsis Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of global Sepsis Diagnostics market
  • TABLE 55. List of primary sources, used in the study of global Sepsis Diagnostics market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Sepsis Diagnostics market, research methodology
  • FIG 2. Global Sepsis Diagnostics market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Sepsis Diagnostics market, key trends 2021
  • FIG 5. Global Sepsis Diagnostics market, growth prospects 2022-2028
  • FIG 6. Global Sepsis Diagnostics market, porters 5 force model
  • FIG 7. Global Sepsis Diagnostics market, pest analysis
  • FIG 8. Global Sepsis Diagnostics market, value chain analysis
  • FIG 9. Global Sepsis Diagnostics market by segment, 2019 & 2028 (USD Billion)
  • FIG 10. Global Sepsis Diagnostics market by segment, 2019 & 2028 (USD Billion)
  • FIG 11. Global Sepsis Diagnostics market by segment, 2019 & 2028 (USD Billion)
  • FIG 12. Global Sepsis Diagnostics market by segment, 2019 & 2028 (USD Billion)
  • FIG 13. Global Sepsis Diagnostics market by segment, 2019 & 2028 (USD Billion)
  • FIG 14. Global Sepsis Diagnostics market, regional snapshot 2019 & 2028
  • FIG 15. North America Sepsis Diagnostics market 2019 & 2028 (USD Billion)
  • FIG 16. Europe Sepsis Diagnostics market 2019 & 2028 (USD Billion)
  • FIG 17. Asia pacific Sepsis Diagnostics market 2019 & 2028 (USD Billion)
  • FIG 18. Latin America Sepsis Diagnostics market 2019 & 2028 (USD Billion)
  • FIG 19. Global Sepsis Diagnostics market, company market share analysis (2021)
目次

Global Sepsis Diagnostics Market is valued at approximately USD 461.47 million in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% over the forecast period 2022-2028. Sepsis can be defined as the body's reaction to infection as bacterial, viral, fungal, parasitic which may lead to a systemic inflammatory reaction and eventually organ dysfunction and/or failure. The rising incidence of hospital-acquired infections and high incidence of sepsis has led to the adoption of Sepsis Diagnostics across the forecast period. For Instance: as per the CDC incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide. Also, with the development of rapid diagnostic and growth opportunities in emerging economies, the adoption & demand for Sepsis Diagnostics is likely to increase the market growth during the forecast period. However, lack of skilled professionals and high cost of automated diagnostic devices impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Sepsis Diagnostics market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of a highly developed healthcare system, high adoption of innovative sepsis diagnostic technologies. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as rising number of surgical procedures, increasing incidence of healthcare-associated infections would create lucrative growth prospects for the Sepsis Diagnostics market across Asia-Pacific region.

Major market players included in this report are:

Axis-Shield Diagnostics (UK)

Becton, Dickinson and Company (US)

Danaher Corporation (US)

Thermo Fisher Scientific (US)

Bruker Corporation (US)

Abbott Laboratories (US)

Axis-Shield Diagnostics (UK)

Quidel Corporation (US)

EKF Diagnostics (UK)

Seegene Inc. (South Korea)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Blood Culture Media

Assays & Reagents

Instruments

Software

By Technology:

Blood Culture

Immunoassays

Molecular Diagnostics

Flow Cytometry

Microfluidics

Biomarkers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Sepsis Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Sepsis Diagnostics Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Sepsis Diagnostics Market, by Product, 2020-2028 (USD Billion)
    • 1.2.3. Sepsis Diagnostics Market, by Technology, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Sepsis Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Sepsis Diagnostics Market Dynamics

  • 3.1. Sepsis Diagnostics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising incidence of hospital-acquired infections
      • 3.1.1.2. High incidence of sepsis
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of skilled Professionals
      • 3.1.2.2. High cost of automated diagnostic devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Development of rapid diagnostic
      • 3.1.3.2. Growth opportunities in emerging economies

Chapter 4. Global Sepsis Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Sepsis Diagnostics Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Sepsis Diagnostics Market by Product, Performance - Potential Analysis
  • 6.3. Global Sepsis Diagnostics Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
  • 6.4. Sepsis Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Blood Culture Media
    • 6.4.2. Assays & Reagents
    • 6.4.3. Instruments
    • 6.4.4. Software

Chapter 7. Global Sepsis Diagnostics Market, by Technology

  • 7.1. Market Snapshot
  • 7.2. Global Sepsis Diagnostics Market by Technology, Performance - Potential Analysis
  • 7.3. Global Sepsis Diagnostics Market Estimates & Forecasts by Technology, 2019-2028 (USD Billion)
  • 7.4. Sepsis Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Blood Culture
    • 7.4.2. Immunoassays
    • 7.4.3. Molecular Diagnostics
    • 7.4.4. Flow Cytometry
    • 7.4.5. Microfluidics
    • 7.4.6. Biomarkers

Chapter 8. Global Sepsis Diagnostics Market, Regional Analysis

  • 8.1. Sepsis Diagnostics Market, Regional Market Snapshot
  • 8.2. North America Sepsis Diagnostics Market
    • 8.2.1. U.S. Sepsis Diagnostics Market
      • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2028
      • 8.2.1.2. Technology breakdown estimates & forecasts, 2019-2028
    • 8.2.2. Canada Sepsis Diagnostics Market
  • 8.3. Europe Sepsis Diagnostics Market Snapshot
    • 8.3.1. U.K. Sepsis Diagnostics Market
    • 8.3.2. Germany Sepsis Diagnostics Market
    • 8.3.3. France Sepsis Diagnostics Market
    • 8.3.4. Spain Sepsis Diagnostics Market
    • 8.3.5. Italy Sepsis Diagnostics Market
    • 8.3.6. Rest of Europe Sepsis Diagnostics Market
  • 8.4. Asia-Pacific Sepsis Diagnostics Market Snapshot
    • 8.4.1. China Sepsis Diagnostics Market
    • 8.4.2. India Sepsis Diagnostics Market
    • 8.4.3. Japan Sepsis Diagnostics Market
    • 8.4.4. Australia Sepsis Diagnostics Market
    • 8.4.5. South Korea Sepsis Diagnostics Market
    • 8.4.6. Rest of Asia Pacific Sepsis Diagnostics Market
  • 8.5. Latin America Sepsis Diagnostics Market Snapshot
    • 8.5.1. Brazil Sepsis Diagnostics Market
    • 8.5.2. Mexico Sepsis Diagnostics Market
  • 8.6. Rest of The World Sepsis Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Axis-Shield Diagnostics (UK)
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Becton, Dickinson and Company (US)
    • 9.2.3. Danaher Corporation (US)
    • 9.2.4. Thermo Fisher Scientific (US)
    • 9.2.5. Bruker Corporation (US)
    • 9.2.6. Abbott Laboratories (US
    • 9.2.7. Axis-Shield Diagnostics (UK)
    • 9.2.8. Quidel Corporation (US)
    • 9.2.9. EKF Diagnostics (UK)
    • 9.2.10. Seegene Inc. (South Korea)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption